Skip to main content
All lobbying filings

SIEMENS MEDICAL SOLUTIONS USA, INC

Lobbying for SIEMENS MEDICAL SOLUTIONS USA, INC

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $700,000.00 expenses · posted Apr 20, 2026

Official filing document

 Bills named in this filing 17
  • HR 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • HR 6197
    Health Tech Investment Act
  • S 1399
    Health Tech Investment Act
  • HR 5269
    RESULTS Act
  • S 2761
    RESULTS Act
  • HR 1406
    Lung Cancer Screening and Prevention Act of 2025
  • HR 2319
    Women and Lung Cancer Research and Preventive Services Act of 2025
  • S 1157
    Women and Lung Cancer Research and Preventive Services Act of 2025
  • HR 6178
    Increasing Access to Lung Cancer Screening Act
  • HR 842
    Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
  • S 339
    Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
  • HR 4417
    Mobile Cancer Screening Act
  • S 2927
    Mobile Cancer Screening Act
  • HR 2477
    Portable Ultrasound Reimbursement Equity Act of 2025
  • S 1168
    Portable Ultrasound Reimbursement Equity Act of 2025
  • HR 5304
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
 Lobbying activity 5
Health Issues

Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to data privacy standards and transparency; and Issues related to right to repair for medical devices.

Medicare/Medicaid

H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.

Trade (domestic/foreign)

Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review; Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.

Tariff (miscellaneous tariff bills)

Implementation of P. L. 87-794 - Trade Expansion Act - issues related to domestic supply chain considerations for medical devices in regard to Section 232 investigations; and Implementation of P.L. 93-618 - Trade Act - issues related to domestic supply chain considerations for medical devices in regards to Section 301 investigations and reciprocal tariffs.

Budget/Appropriations

H.R. 5304 / S. S587 / H. Rept. 119-271 / S. Rept. 117-55 - Labor-HHS-Education Appropriation Act, FY 2026;

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem